| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/09/2009 | WO2009085945A1 Benzothiazole and benzoxazole derivatives and methods of use |
| 07/09/2009 | WO2009085766A2 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 07/09/2009 | WO2009085226A2 Inhibitors of cdc2-like kinases (clks) and methods of use thereof |
| 07/09/2009 | WO2009085223A1 Combination of metformin r-(+)-lipoate and antihyperglycemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 07/09/2009 | WO2009085198A2 Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 07/09/2009 | WO2009084732A1 Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |
| 07/09/2009 | WO2009084497A1 Methyl-substituted piperidine derivative |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084477A1 Preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084471A1 Emulsion preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084275A1 Composition for oral administration |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084122A1 Iron-enriched composition |
| 07/09/2009 | WO2009083614A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | WO2009083553A1 Azine compounds as glucokinase activators |
| 07/09/2009 | WO2009083526A1 Novel compounds |
| 07/09/2009 | WO2009082883A1 Antiobesity composition |
| 07/09/2009 | WO2009082881A1 Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof |
| 07/09/2009 | WO2009062874A3 Benzimidazole derivatives and their use as fxr agonists |
| 07/09/2009 | WO2009053793A3 Use of volatile oil from plants in preparing medicaments for preventing and treating diabetes |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2009024889A3 Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| 07/09/2009 | WO2009017755A3 Cb1 antagonists and inverse agonists |
| 07/09/2009 | WO2009008991A3 Dna-pkcs modulates energy regulation and brain function |
| 07/09/2009 | WO2008039087A8 Indoline derivatives and uses thereof |
| 07/09/2009 | US20090176889 Compounds for the treatment of metabolic disorders |
| 07/09/2009 | US20090176885 Compounds for the treatment of metabolic disorders |
| 07/09/2009 | US20090176863 Thiophene derivative ppar modulators |
| 07/09/2009 | US20090176861 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176856 Muscarinic receptor antagonists |
| 07/09/2009 | US20090176854 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176847 Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof |
| 07/09/2009 | US20090176843 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 07/09/2009 | US20090176835 Pharmaceutical composition for suppression of the expression of atp citrate lyase and use thereof |
| 07/09/2009 | US20090176826 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/09/2009 | US20090176816 Drug composition for treating 2 type diabetes and diabetic chronicity complications |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
| 07/09/2009 | US20090176798 New compounds III |
| 07/09/2009 | US20090176793 3-(l,3-BENZODIOXOL-5-YL)-6-(4-CYCLOPROPYLPIPERAZIN-l-YL)-PYRIDAZINE, ITS SALTS AND SOLVATES AND ITS USE AS HISTAMINE H3 RECEPTOR ANTAGONIST |
| 07/09/2009 | US20090176783 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 07/09/2009 | US20090176760 Tricyclic compounds |
| 07/09/2009 | US20090176754 Crystalline Form of the Compound A-348441 |
| 07/09/2009 | US20090176720 Compositions containing piperacillin and tazobactam useful for injection |
| 07/09/2009 | US20090176718 Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome |
| 07/09/2009 | US20090176712 Peptides with Efficacy in Rescuing Melanocortin-4 Receptor Polymorphic Agonist Signaling |
| 07/09/2009 | US20090176704 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 07/09/2009 | US20090176697 Method to obtain the human Chorionic Gonadotropin (hCG)/cyclodextrin complex for oral administration, product obtained by this method and clinical and therapeutic use of the complex human Chorionic Gonadotropin (hCG)/cyclodextrin |
| 07/09/2009 | US20090176692 Amidated insulin glargine |
| 07/09/2009 | US20090175969 Formulation for treating obesity and associated metabolic syndrome |
| 07/09/2009 | US20090175961 Dietary Supplement Compositions |
| 07/09/2009 | US20090175841 Compounds for Improving Nutritional Status, Cognition and Survival |
| 07/09/2009 | US20090175840 Insulin formulations for insulin release as a function of tissue glucose levels |
| 07/09/2009 | US20090175832 Isolated Embryonic-Like Stem Cells Derived From Human Umbilical Cord Blood |
| 07/09/2009 | US20090175831 Adaptable messenger ribonucleic acid medical treatment device to manage diabetes mellitus |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2711141A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710461A1 Benzimidazole compounds |
| 07/09/2009 | CA2710458A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | CA2710454A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | CA2710452A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/09/2009 | CA2709961A1 Benzothiazole and benzoxazole derivatives and methods of use |
| 07/09/2009 | CA2706735A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives, preparation process and medicinal use thereof |
| 07/08/2009 | EP2077326A1 Novel nucleic acid |
| 07/08/2009 | EP2077267A1 Fused heterocyclic compound |
| 07/08/2009 | EP2077266A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 07/08/2009 | EP2077262A1 Iminopyridine derivative and use thereof |
| 07/08/2009 | EP2076509A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/08/2009 | EP2076503A2 C-phenyl glycitol compound for the treatment of diabetes |
| 07/08/2009 | EP2076494A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 07/08/2009 | EP2076273A2 Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin |
| 07/08/2009 | EP2076265A2 Ketoconazole enantiomer in humans |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |